Grant: Discovery Grants Program - Individual
McGill University
$40,000.00
Design and synthesis of molecular tools that modulate metabolic pathways- implications for drug discovery
EF 2011-12
Résumé
Oncogenesis and viral replication require energy and macromolecular precursors that are often derived from the metabolic networks of the host cell. Cancer and viral infections also disrupt the normal production of numerous host proteins that are crucial to cell physiology. My research program aims to provide molecular tools that can be used to explore the biochemical role of metabolic enzymes and other host proteins that are involved in these important disease states. Towards this goal, my group embraces a Chemical Biology approach in addressing key questions that probe the role and interactions between important human proteins, in the context of an intact biological system. These studies can provide valuable innovations at the early stages of new drug discovery programs aiming at developing novel antitumor and antiviral human therapeutics.
One of our key objectives is to develop robust synthetic methodologies that are amenable to high throughput parallel synthesis of compounds, which can serve as tools in investigations of complex networks of bimolecular interactions. Currently, we are following a structure-based approach to design heterocyclic and peptidomimetic scaffolds that can selectively modulate the catalytic activity of human farnesyl pyrophosphate synthase (hFPPS) in both cell-based assays and animal models. The hFPPS enzyme occupies a strategic location at the first committed step of the mevalonate pathway leading to protein prenylation of the Ras oncogenic proteins. In addition, this enzyme is implicated in the interferon-induced innate immune response against viral infections in humans. Therefore, hFPPS appears to play a crucial role at a cross-over point between the host's metabolism and innate immunity. Studies in this area require a seamless integration of synthetic organic chemistry, biochemistry, structural research and bioinformatics, and provide an excellent training ground for students and research fellows (HQPs) interested in pursuing an industrial or academic career in biomedical or pharmaceutical sciences.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
121762-2010
Name nom
Tsantrizos, Youla
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
40000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
2
Nb partie
5
Application title
Design and synthesis of molecular tools that modulate metabolic pathways- implications for drug discovery
Keyword
NSERC
Application summary
Oncogenesis and viral replication require energy and macromolecular precursors that are often derived from the metabolic networks of the host cell. Cancer and viral infections also disrupt the normal production of numerous host proteins that are crucial to cell physiology. My research program aims to provide molecular tools that can be used to explore the biochemical role of metabolic enzymes and other host proteins that are involved in these important disease states. Towards this goal, my group embraces a Chemical Biology approach in addressing key questions that probe the role and interactions between important human proteins, in the context of an intact biological system. These studies can provide valuable innovations at the early stages of new drug discovery programs aiming at developing novel antitumor and antiviral human therapeutics.
One of our key objectives is to develop robust synthetic methodologies that are amenable to high throughput parallel synthesis of compounds, which can serve as tools in investigations of complex networks of bimolecular interactions. Currently, we are following a structure-based approach to design heterocyclic and peptidomimetic scaffolds that can selectively modulate the catalytic activity of human farnesyl pyrophosphate synthase (hFPPS) in both cell-based assays and animal models. The hFPPS enzyme occupies a strategic location at the first committed step of the mevalonate pathway leading to protein prenylation of the Ras oncogenic proteins. In addition, this enzyme is implicated in the interferon-induced innate immune response against viral infections in humans. Therefore, hFPPS appears to play a crucial role at a cross-over point between the host's metabolism and innate immunity. Studies in this area require a seamless integration of synthetic organic chemistry, biochemistry, structural research and bioinformatics, and provide an excellent training ground for students and research fellows (HQPs) interested in pursuing an industrial or academic career in biomedical or pharmaceutical sciences.